C. Diff News and Research

RSS

STERIPLEX HC kills MRSA and other pathogens in record time

STERIPLEX® Health Care (HC) is a new Sterilant/Sporicide, Tuberculocide, and Bactericide, which has recently received Federal EPA Registration. STERIPLEX® HC sets new standards, killing MRSA, spores and other pathogens in a fraction of the time of competing products while remaining safe to people and the environment.

18 Dec 2009

Medicare expenditures less for POHs compared to non-POHs, says new study

The cost to Medicare of a patient receiving treatment at a physician owned and operated hospitals is "4.6 to 6.00% lower" than hospitals not run by physicians, according to a new study by Oxford Outcomes, an internationally respected research agency.

18 Dec 2009

Medical Nutrition launches Diff-Stat pre- and probiotic supplement to prevent the onset of AAD and C-diff

Medical Nutrition USA, Inc., a developer and distributor of uniquely engineered, nutrition-medicine products, announced the introduction of Diff-Stat™, a new supplement containing pre- and probiotics to help restore and maintain beneficial bacteria that prevent the onset of antibiotic-associated diarrhea (AAD) and clostridium difficile (C-diff).

24 Nov 2009

Stomach infection on the rise in outpatient settings; symptoms can range from diarrhea to life-threatening inflammation

Mayo Clinic researchers have found that a sometimes deadly stomach bug, Clostridium difficile, (http://www.mayoclinic.org/c-difficile/) is on the rise in outpatient settings.

27 Oct 2009

Pennsylvania Patient Safety Authority's initiative to raise awareness of healthcare-associated infections

The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).

14 Oct 2009

Biocodex secures consumer distribution with CVS stores nationwide for its Florastor

As part of its continued expansion throughout the U.S. retail market, Biocodex, Inc., the U.S. arm of the French manufacturer of Florastor® and Florastor® Kids, has secured consumer distribution with CVS stores nationwide beginning this month. Florastor will be placed on-shelf in the stomach/digestives aisle, while Florastor Kids will be available upon request “behind the counter.”

8 Oct 2009

Bioneutral Group holds scientific and business discussions with major health care companies

BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU), a specialty chemical technology based Life Science Company, announced discussions with four of the world’s largest health care companies.

25 Aug 2009

Old drug Auranofin may lead to new antibiotics

A mineral found at health food stores could be the key to developing a new line of antibiotics for bacteria that commonly cause diarrhea, tooth decay and, in some severe cases, death.

1 Jun 2009

New report shows high Clostridium difficile infection rates in U.S. hospitals

Consumers Union called on hospitals today to take more aggressive steps to protect patients from Clostridium difficile (C.-diff.) infections in light of a new report showing that they are much more common than previous estimates had indicated. As the rate of hospital acquired C.-diff. infections has jumped in recent years, an increasing number of patients have developed antibiotic-resistant strains of the infection that are more difficult to treat and more deadly.

11 Nov 2008

Maggots the key to fighting superbugs

Scientists at Swansea University in Wales have discovered that maggots may hold the key to fighting superbugs.

5 Aug 2008

Superbug genome sequenced

The genome of a newly-emerging superbug, commonly known as Steno, has just been sequenced. The results reveal an organism with a remarkable capacity for drug resistance. The research was carried out by scientists at the Wellcome Trust Sanger Institute near Cambridge and the University of Bristol.

6 May 2008

Anadis licenses antibody technologies from ImmuCell

Anadis Limited, an Australian-based biotechnology company focused on milk derived polyclonal antibodies and other milk-derived bioactives, announced today that it had signed a final agreement with ImmuCell Corporation, a biotechnology company headquartered in Portland, Maine, USA.

11 Mar 2008

Hospital chairman quits over superbug scandal

Following a report that as many as 345 patients may have died from an infection contracted at a British hospital, the chairman of the hospital trust at the centre of the infection scandal has resigned.

16 Oct 2007

Off with the sleeves as battle of the superbug begins

The National Health Service (NHS) in the UK, battling to control the spread of superbugs like MRSA, will in future ban the signature long-sleeved white coats, favoured by doctors.

17 Sep 2007

Scientists tackle deadly hospital superbugs

It infiltrates hospitals as microscopic spores. Its defences are so strong it can resist most antibiotics. And it kills three times as many people every year as MRSA. But scientists at The University of Nottingham are amassing an arsenal of weapons in preparation for counter offensive against the most deadly of hospital superbugs.

4 Jul 2007

New device rapidly diagnoses gastrointestinal disease by 'reading' the odour of biological fluids

A pioneering new device that could help over four billion adults and children who suffer from infectious diarrhoea in the developing world and reduce outbreaks of diseases such as clostridium difficile (C.Diff) in UK hospital wards is the winner of this year's University of Bristol's New Enterprise Competition.

4 Jul 2007

Discovery of chemical profiles for infectious diarrhoea

Academics from the Universities of the West of England and Bristol have found that faeces from healthy people and those with infectious diarrhoea differ significantly in their chemical composition and could be used to diagnose quickly diseases such as Clostridium difficile (C. Diff.).

22 May 2007

New method for rapid diagnosis of intestinal illnesses

Academics have found, for the first time, smells from healthy faeces and people with infectious diarrhoea differ significantly in their chemical composition and could be used to diagnose quickly diseases such as Clostridium difficile (C. Diff.).

27 Feb 2007

Enter hospital at your peril!

As many as two dozen patients at a British hospital have died after contracting the virulent stomach bug Clostridium difficile (C. diff).

3 Jul 2006

Superbug possibly the same as US killer strain

Microbiologists at the Health Protection Agency suspect that the superbug which has already caused 12 deaths at Stoke Mandeville Hospital, in Buckinghamshire, may be the same strain that has spread in many American hospitals since 2001, and killed more than 100 patients in Quebec, Canada, last year.

8 Jun 2005